199 related articles for article (PubMed ID: 2247927)
1. Indications for use of ketoconazole in management of metastatic prostate cancer.
Lowe FC; Bamberger MH
Urology; 1990 Dec; 36(6):541-5. PubMed ID: 2247927
[TBL] [Abstract][Full Text] [Related]
2. Hormone therapy of prostatic bone metastases.
Huben RP
Adv Exp Med Biol; 1992; 324():305-16. PubMed ID: 1492625
[TBL] [Abstract][Full Text] [Related]
3. Current treatment of advanced prostate cancer.
Ismail M; Gomella LG
Tech Urol; 1997; 3(1):16-24. PubMed ID: 9170220
[TBL] [Abstract][Full Text] [Related]
4. Treating prostate cancer. Part V: androgen deprivation and chemotherapy.
Harv Mens Health Watch; 1999 Dec; 4(5):5-8. PubMed ID: 10564905
[No Abstract] [Full Text] [Related]
5. Endocrine therapy of prostate cancer.
Bare RL; Torti FM
Cancer Treat Res; 1998; 94():69-87. PubMed ID: 9587683
[TBL] [Abstract][Full Text] [Related]
6. Physiologic basis of endocrine therapy for prostatic cancer.
McConnell JD
Urol Clin North Am; 1991 Feb; 18(1):1-13. PubMed ID: 1899494
[TBL] [Abstract][Full Text] [Related]
7. [New hormonal treatments of metastatic prostatic cancer. Review of the literature].
Dubost JJ; Sauvezie B; Ristori JM; Thevenet JP; Rampon S
Rev Rhum Mal Osteoartic; 1985 Oct; 52(10):577-85. PubMed ID: 3909364
[No Abstract] [Full Text] [Related]
8. Hormonal therapy for stage D cancer of the prostate.
Gudziak MR; Smith AY
West J Med; 1994 Apr; 160(4):351-9. PubMed ID: 8023485
[TBL] [Abstract][Full Text] [Related]
9. Ketoconazole therapy for hormonally refractive metastatic prostate cancer.
Johnson DE; Babaian RJ; von Eschenbach AC; Wishnow KI; Tenney D
Urology; 1988 Feb; 31(2):132-4. PubMed ID: 3341098
[TBL] [Abstract][Full Text] [Related]
10. [Cancer of the prostate: new hormone therapies].
Namer M; Boublil JL; Kather R; Cavaglione G
Bull Cancer; 1986; 73(1):47-55. PubMed ID: 3779122
[TBL] [Abstract][Full Text] [Related]
11. [Castration resistant prostate cancer 2011].
Miller K
Aktuelle Urol; 2011 Mar; 42(2):95-102. PubMed ID: 21437832
[TBL] [Abstract][Full Text] [Related]
12. Commentary on "Comparison of abiraterone acetate versus ketoconazole in patients with metastatic castration resistant prostate cancer refractory to docetaxel." Peer A, Gottfried M, Sinibaldi V, Carducci MA, Eisenberger MA, Sella A, Leibowitz-Amit R, Berger R, Keizman D, Department of Oncology, Rambam Medical Center, Haifa, Israel.: Prostate 2014 Apr;74(4):433-40; doi:10.1002/pros.22765. [Epub 2013 Dec 11].
Trump D
Urol Oncol; 2016 May; 34(5):247. PubMed ID: 25907623
[TBL] [Abstract][Full Text] [Related]
13. Complete androgen blockade for the treatment of prostate cancer.
Labrie F; Dupont A; Belanger A
Important Adv Oncol; 1985; ():193-217. PubMed ID: 3916740
[No Abstract] [Full Text] [Related]
14. Prostate cancer: current and evolving strategies.
Cersosimo RJ; Carr D
Am J Health Syst Pharm; 1996 Feb; 53(4):381-96; quiz 446-8. PubMed ID: 8673658
[TBL] [Abstract][Full Text] [Related]
15. The use of ketoconazole in the emergency management of disseminated intravascular coagulation due to metastatic prostatic cancer.
Lowe FC; Somers WJ
J Urol; 1987 May; 137(5):1000-2. PubMed ID: 3573156
[TBL] [Abstract][Full Text] [Related]
16. Combined androgen blockade: the gold standard for metastatic prostate cancer.
McLeod DG; Crawford ED; DeAntoni EP
Eur Urol; 1997; 32 Suppl 3():70-7. PubMed ID: 9267789
[TBL] [Abstract][Full Text] [Related]
17. Endocrine treatment of prostate cancer.
Tammela T
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
[TBL] [Abstract][Full Text] [Related]
18. Ketoconazole high dose (H.D.) in the management of hormonally pretreated patients with progressive metastatic prostate cancer.
Debruyne FM; Witjes FA
Prog Clin Biol Res; 1987; 243A():301-13. PubMed ID: 3659003
[TBL] [Abstract][Full Text] [Related]
19. [Hormonal therapy (medical orchiectomy) in prostatic carcinoma].
Studer UE; Münch D
Schweiz Med Wochenschr; 1990 Jun; 120(24):881-7. PubMed ID: 2193381
[TBL] [Abstract][Full Text] [Related]
20. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline.
Loblaw DA; Virgo KS; Nam R; Somerfield MR; Ben-Josef E; Mendelson DS; Middleton R; Sharp SA; Smith TJ; Talcott J; Taplin M; Vogelzang NJ; Wade JL; Bennett CL; Scher HI;
J Clin Oncol; 2007 Apr; 25(12):1596-605. PubMed ID: 17404365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
